BioPharma Synergies


BioPharma Synergies is committed to advancing the pharmaceutical and chemical industries through strategic APIs, process development, tech transfers, and innovative drug delivery formulations. Based in Barcelona with international representation, the company focuses on supporting global market expansion, especially in APIs, intermediates, and proprietary formulations like Orodispersible products. Their expertise includes developing synthesis processes, securing patents, and facilitating European and US market entry through tech transfers. The company also offers intermediates for strategic APIs, collaborating with manufacturers across Europe, and provides comprehensive R&D support to optimize production and regulatory compliance.

Industries

manufacturing
pharmaceutical
wholesale

Nr. of Employees

small (1-50)

BioPharma Synergies

Gran Via de Carles III, 41, Esol. – 2ª 08028 – Barcelona, Spain


Products

Orodispersible formulation technology platform

A formulation platform for orodispersible powders (stick packs), orodispersible tablets and chewable tablets designed for taste masking, administration without water and suitability for patients with dietary restrictions.

CAS-referenced strategic API and intermediate portfolio

A cataloged inventory of strategic active pharmaceutical ingredients and advanced intermediates referenced to CAS identifiers, used to support sourcing, qualification and commercial supply activities and specification matching.


Services

Provide commercial representation, market development, promotion, licensing and distribution management for pharmaceutical ingredients and finished drug products in Spain and other European territories.

Identify, qualify and procure manufacturers and suppliers of starting materials, intermediates and APIs in China and India; manage supplier engagement, documentation and supply coordination for European markets. Maintain CAS-referenced portfolio to support sourcing.

Develop and optimize laboratory-scale synthetic processes for intermediates and APIs to meet client or pharmacopeial specifications and prepare candidates for scale-up and industrial manufacturing.

Manage transfer of processes to industrial manufacturers, adapt processes to regulatory quality standards and coordinate production with accredited GMP manufacturers.

Design and develop orodispersible powders (stick packs), orodispersible tablets and chewable tablets with taste-masking and water-free administration features; support scale-up and IP protection.

Prepare registration dossiers and submit marketing authorization applications for products in the EU, and support licensing or transfer of marketing authorisations to third parties.

View All Services

Expertise Areas

  • API process development
  • Technology transfer and manufacturing scale-up
  • Orodispersible and chewable formulation development
  • Regulatory dossier preparation and EU product registration
  • Show More (7)

Key Technologies

  • Orodispersible and rapid-dispersing oral formulation platforms
  • Taste-masking formulation techniques
  • Chemical synthesis process development
  • Scale-up methodologies and tech transfer
  • Show More (4)

News & Updates

BIO Europe 2024

PharmaVenue Barcelona January 20-21, 2025

European patent granting for triptans

In 2023, BioPharma Synergies was granted a European patent for its triptan formulations.

PCT publications of Orodispersible powder compositions

In 2022, the company published PCT applications for compositions including antihistamines and platform patents for various dosage forms.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.